
Expert Adviser at IBT Partners
Paris Area, France

Expert Adviser at IBT Partners
Paris Area, France
I have had extensive experience of global business in life sciences across the Nordic countries, Europe-EMEA, USA, Asia and now in France. I have enjoyed the challenge of identifying strategic options in new markets for Life Science SMEs and investment bankers. As a qualified management consultant, specialized in strategy and finance, I am deeply involved in corporate discussions and decision-making. This, coupled with my MBA, provides me with both a detailed and a wide-view perspective. I have consistently achieved above-average performance in all of my roles- I like challenges.
Fund raising, M&A, licensing deals, technology transfer, alliances and partnership, international business development,sales and marketing, market research, corporate design and communication, strategic management of growth, strategy development investment valuations and decisions, financial modeling , technology assessment, cost-cutting, reorganization and HR executive search.
(Internet industry)
November 2008 — Present (9 months)
THE INTERNATIONAL INTERNETTV CHANNEL
FOR BIOTECH & LIFE SCIENCE!
With support from EuropaBio, BiolifeTV.com
is the first ever InternetTV channel for the biotech & life science community.
Seize this unique opportunity to promote your company
and its products & services to high-value customers with a video for free.
(Biotechnology industry)
October 2008 — Present (10 months)
Market research and business development for the Nordic countries for the Foundation. expert Advisor for firms willing to undertake basic research in the medical area and technologies and collaborate with one of the 3 universities the Foundation represent ENS, ESPCI and The Institute Marie Curie.
Le CNRS, l’INSERM, l’Ecole Normale Supérieure (ENS), L’Ecole Supérieure de Physique et de Chimie Industrielles (ESPCI) et l’Institut Curie ont bâti ensemble un centre d’excellence transdisciplinaire et inter-établissement dans la logique des Partenariats Public-Privé : La Fondation Pierre-Gilles de Gennes pour la Recherche.
(Biotechnology industry)
October 2008 — Present (10 months)
BioQuanta is a biotechnology research and development company providing innovative and powerful solutions to biotechnology companies, pharmaceutical laboratories, food and cosmetics industries through high-tech drug design and molecular modeling, and their comparison to biological results.
“… Each day, using the synergy of manpower and of competences, we work to extend our knowledge. Each day, we develop our knowledge on the most advanced technologies in order to master them more. Each day, we work to validate them in order to open doors to broader applications and set the standard"
(Biotechnology industry)
October 2008 — Present (10 months)
BioQuest Solutions Pvt. Ltd. is India's premier clinical science and marketing support organization. BioQuest’s core expertise lies in the areas of pharmaceutical marketing, clinical research, clinical insights and medical communication, covering the entire gamut of Knowledge Process Outsourcing (KPO) in the healthcare industry.
Your Thinking Partners for Success
BioQuest aims to become a long-term thinking partner in the success of your product(s) and thus your success. We do this by providing high quality medical communication services that are tailored to meet your specific needs. Our services are founded on credible and authentic scientific content and combined with an excellent understanding of the competitive needs of your market and the need to build the brand.
BioQuest takes a flexible approach to how we work with you, whether for an individual project or a fully comprehensive and Integrated Product Program (CIPP). Tt
(Biotechnology industry)
2008 — Present (1 year)
Spectrum Clinical Research is an one-of-its-kind patient-focused drug development organization. Our aim is to provide quality clinical research support to pharmaceutical companies and Contract Research Organizations in order to facilitate the development of new chemical entities, evolve innovative therapies and support research on novel drug delivery systems, keeping the well-being & safety of patients at the core of our every endeavor ensuring compliance to the highest regulatory, scientific & ethical standards by ICH, WHO, USFDA.
(Privately Held; Management Consulting industry)
May 2008 — Present (1 year 3 months)
Business development projetc for teh Life Sciences and health care sectors
(Biotechnology industry)
July 2006 — Present (3 years 1 month)
• M&A advisor
* Commercial development of high tech Life Science SMEs internationally
* Search for strategic alliances and partnerships
• Fundraising for ventures (VC, licensing)
• Business development projects for SMEs in the Life Science industry (from to Europe/Asia/USA/Americas)
• Development and evaluation of business plans
• Lecturing in marketing, finance, new business development and strategy at HEC, ESG and INSEAD
• Development of the international market penetration strategies
* Technology assesment and valuation
* Market research and marketing
* Business and fincacial plans
* Commercialization of technologies and innovations, products and services
(Public Company; 10,001 or more employees; ROK; Industrial Automation industry)
September 2005 — January 2006 (5 months)
• Responsibilities for key account such as Sanofi-Aventis, Servier, GSK, Leo.
• Management of customer relations (sales and marketing, customer feedback and troubleshooting)
(Public Company; 1001-5000 employees; STE; Medical Devices industry)
August 2003 — September 2005 (2 years 2 months)
• Appointed as Sales Manager for capital equipment such as autoclaves, surface sterilizers (vaporized hydrogen peroxide), dry heaters and washers for the pharmaceutical research sector; successful entry into the French life science and research market places.
• Penetrated a mature market place delivering over half the sales revenues for the company with sales of $2.5m, surpassing set KPIs for the region by over 20%.
• Developed and enhanced processes as part of the tendering and sales process for the European Group, resulting in greater transparency, saving costs and developed a culture of open communications.
(Biotechnology industry)
January 2001 — August 2003 (2 years 8 months)
• Financial analysis of firms within the Finnish biotechnology industry for a financial insitution
• Definition and implementation of new sales and marketing strategies for a executive training firm
• Reengineering of the CRM system and introduction of the key account management concept
• Defintion of business trategies for a business incubator
• Implementation of new valuation methods and procedures for an investment banker
• Definition of a technology strategy for high technology firm in order to maximize NPV.
• New product development and globalization strategies for TEKES, the National Technology Agency finances research and development (R&D) projects of companies and universities in Finland. The funds are awarded from state budget via the Ministry of Trade and Industry.
• Analysis of new product specification, a market research project for SITRA, the Finnish National Fund for Research and Development,.
(Biotechnology industry)
August 1998 — December 2000 (2 years 5 months)
• Responsibilities for global marketing (marketing materials, congresses and exhibitions)
• Corporate managerial responsibilities (budgeting, internal development projects)
* Member of the Executive board
* Annual strategy planning
• Customer Relations Management (customer training, customer relation systems, trouble-shooting and feedback)
(Medical Devices industry)
June 1996 — August 1998 (2 years 3 months)
• Definition and implementation of new global marketing programs
• Management of customer relations (customer training, customer feedback and troubleshooting)
• Successful new product development and market introduction of new products
• Production planning and inventory strategies
• Supply chain management of products of responsibility
• Business plans, definition of ROI on new development projects
• Definition of global pricing strategies.
• Thesis on preservative effectiveness in in vitro diagnostic products
Ph D student , Stratégie et Politique d'Entreprise , 2007 — 2008
TA at HEC MBA programs in Marketing
MBA , Finance, Strategy and International Business , 1999 — 2001
Graduated within the top 5%
M Sc , Microbiology, Biocehmistry , 1991 — 1999
Biotechnology industry, pharmaceutical industry, research, management consulting, investment decision, investment planning, business plans, marketing plans.